These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12629150)

  • 1. Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils.
    Hor WS; Huang WL; Lin YS; Yang BC
    J Leukoc Biol; 2003 Mar; 73(3):363-8. PubMed ID: 12629150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of enhanced transcription of the IL-10 gene in T cells, upon contact with human glioma cells, by Fas signaling through a protein kinase A-independent pathway.
    Yang BC; Lin HK; Hor WS; Hwang JY; Lin YP; Liu MY; Wang YJ
    J Immunol; 2003 Oct; 171(8):3947-54. PubMed ID: 14530312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
    Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
    Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
    Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
    J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
    Tani E; Kitagawa H; Ikemoto H; Matsumoto T
    FEBS Lett; 2001 Aug; 504(1-2):53-8. PubMed ID: 11522296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
    Shinohara H; Yagita H; Ikawa Y; Oyaizu N
    Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
    Luttmann W; Opfer A; Dauer E; Foerster M; Matthys H; Eibel H; Schulze-Osthoff K; Kroegel C; Virchow JC
    Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
    von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
    Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.
    Liles WC; Kiener PA; Ledbetter JA; Aruffo A; Klebanoff SJ
    J Exp Med; 1996 Aug; 184(2):429-40. PubMed ID: 8760796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C6 glioma cells retrovirally engineered to express IL-18 and Fas exert FasL-dependent cytotoxicity against glioma formation.
    Zhang Y; Wang C; Zhang Y; Sun M
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1240-5. PubMed ID: 15555559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.
    Greeneltch KM; Kelly-Welch AE; Shi Y; Keegan AD
    J Immunol; 2005 Oct; 175(8):4999-5005. PubMed ID: 16210602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.
    Aung S; Graham BS
    J Immunol; 2000 Apr; 164(7):3487-93. PubMed ID: 10725701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas receptor (CD95)-mediated apoptosis in leukemic cells.
    Komada Y; Sakurai M
    Leuk Lymphoma; 1997 Mar; 25(1-2):9-21. PubMed ID: 9130610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand.
    Serrao KL; Fortenberry JD; Owens ML; Harris FL; Brown LA
    Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L298-305. PubMed ID: 11159009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.
    Chen XM; Gores GJ; Paya CV; LaRusso NF
    Am J Physiol; 1999 Sep; 277(3):G599-608. PubMed ID: 10484385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.
    Spets H; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
    Blood; 1998 Oct; 92(8):2914-23. PubMed ID: 9763578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
    Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
    J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism.
    Carmona EM; Vassallo R; Vuk-Pavlovic Z; Standing JE; Kottom TJ; Limper AH
    J Immunol; 2006 Jul; 177(1):459-67. PubMed ID: 16785543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.